Specific inhibitor to KRASG12C induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P30CA047904
NIH
Grant: R21CA205727-01
Ministry of Sciences and Technology in China
Grant: 111002319320238000
University of Pittsburgh
Grant: N/A
NCI NIH HHS
Grant: R21 CA205727
National Institutes of Health
Grant: 5R21CA205727-02
Exploring IL-36gamma as a new tumor immune therapy
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
FWCI
6.25
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals